Hong Kong Polytechnic University (PolyU) Friday announced a biotechnology and translational medicine collaboration program between universities from Guangdong-Hong Kong-Macao Greater Bay Area and the United States.
PolyU and its alliance partners from the bay area including Sun Yat-sen University, Shenzhen University, Macao University of Science and Technology will initiate a collaboration with the State University of New York at Buffalo and Roswell Park Comprehensive Cancer Center, to set up the first translational medicine research platform in the bay area.
A Memorandum of Understanding (MOU) signing ceremony was held Friday in PolyU campus in Hong Kong, where representatives from the six institutions signed the MOU.
According to PolyU, the collaboration will pull together various expertise from the collaborating parties and their networks, and signify their commitments in research collaborations in the areas of cancer, genomics, translational medicine, and other related areas in biotechnology and their translation to benefit the global community.
Secretary for Innovation and Technology of Hong Kong government Nicholas Yang said that biotechnology has prospective economic contribution to diversify Hong Kong's existing industry and business, and boundless potential to revolutionise disease treatment and to enhance the quality of life.
"Over the years, Hong Kong has developed a strong foothold in biotechnology research, including biomedicine," he said.
